Skip to content

Insider · CIK 0001216955

MARCUS JOEL S

Reports to the SEC for 9 companies · SOUTH SAN FRANCISCO, CA

Transactions

50

Companies

9

Filings

12

CIK

0001216955

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-10-13TRXBTRex Bio, Inc. · Series B Convertible Preferred StockC Conversion—
2026-10-13TRXBTRex Bio, Inc.C Conversion—
2026-10-08TRXBTRex Bio, Inc. · Stock Option (Right to Buy)A Award—
2026-09-11AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase+$248K
2026-08-17AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase+$231K
2026-05-06AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase+$164K
2026-05-06AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase+$183K
2026-05-05AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase+$86.4K
2026-05-05AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase+$164K
2026-05-05AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase+$70.2K
2026-05-04AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase+$410K
2026-02-12AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase+$418K
2026-02-12AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase+$930K
2026-01-23AREALEXANDRIA REAL ESTATE EQUITIES, INC.D Disposition to Issuer—
2026-01-22AREALEXANDRIA REAL ESTATE EQUITIES, INC.D Disposition to Issuer—
2026-01-09AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award—
2026-01-02AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award—
2025-04-02Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer—
2025-04-02Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer—
2025-04-02Intra-Cellular Therapies, Inc.D Disposition to Issuer−$6.37M
2025-04-02Intra-Cellular Therapies, Inc.D Disposition to Issuer−$1.32M
2025-02-24Intra-Cellular Therapies, Inc.M Exercise/Conversion+$447K
2025-02-24Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion—
2025-01-10AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award—
2025-01-02AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award—
2024-12-31AREALEXANDRIA REAL ESTATE EQUITIES, INC.D Disposition to Issuer—
2024-06-23Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion—
2024-06-23Intra-Cellular Therapies, Inc.M Exercise/Conversion—
2024-06-14Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award—
2024-06-14Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award—
2024-06-06APLTApplied Therapeutics, Inc.A Award—
2024-03-29AREALEXANDRIA REAL ESTATE EQUITIES, INC.D Disposition to Issuer—
2024-03-29AREALEXANDRIA REAL ESTATE EQUITIES, INC.F Tax Payment−$696K
2024-02-26AREALEXANDRIA REAL ESTATE EQUITIES, INC.S Sale−$892K
2024-02-26Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion—
2024-02-26Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion—
2024-02-26Intra-Cellular Therapies, Inc.M Exercise/Conversion+$930K
2024-02-26Intra-Cellular Therapies, Inc.S Sale−$568K
2024-02-26Intra-Cellular Therapies, Inc.S Sale−$1.22M
2024-02-26Intra-Cellular Therapies, Inc.M Exercise/Conversion+$869K
2024-02-26Intra-Cellular Therapies, Inc.S Sale−$20.8K
2024-01-10AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award—
2024-01-05AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award—
2024-01-02AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award—
2023-09-15APLTApplied Therapeutics, Inc.M Exercise/Conversion+$13K
2023-09-15APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion—
2023-06-23Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award—
2023-06-23Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award—
2023-06-06APLTApplied Therapeutics, Inc.A Award—
2023-05-08AREALEXANDRIA REAL ESTATE EQUITIES, INC.S Sale−$917K

Recent filings

12